Evoke Pharma Inc (EVOK)
4.50
-0.06
(-1.32%)
USD |
NASDAQ |
Nov 21, 16:00
4.75
+0.25
(+5.56%)
Pre-Market: 09:08
Evoke Pharma Market Cap: 6.687M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 6.687M |
| November 20, 2024 | 6.776M |
| November 19, 2024 | 6.984M |
| November 18, 2024 | 6.494M |
| November 15, 2024 | 6.806M |
| November 14, 2024 | 6.488M |
| November 13, 2024 | 6.330M |
| November 12, 2024 | 7.43M |
| November 11, 2024 | 7.995M |
| November 08, 2024 | 8.396M |
| November 07, 2024 | 8.400M |
| November 06, 2024 | 8.678M |
| November 05, 2024 | 5.181M |
| November 04, 2024 | 5.118M |
| November 01, 2024 | 5.190M |
| October 31, 2024 | 5.235M |
| October 30, 2024 | 5.772M |
| October 29, 2024 | 5.637M |
| October 28, 2024 | 6.335M |
| October 25, 2024 | 4.742M |
| October 24, 2024 | 4.590M |
| October 23, 2024 | 4.590M |
| October 22, 2024 | 4.832M |
| October 21, 2024 | 4.904M |
| October 18, 2024 | 4.930M |
| Date | Value |
|---|---|
| October 17, 2024 | 4.775M |
| October 16, 2024 | 4.599M |
| October 15, 2024 | 4.572M |
| October 14, 2024 | 4.554M |
| October 11, 2024 | 4.644M |
| October 10, 2024 | 4.760M |
| October 09, 2024 | 4.626M |
| October 08, 2024 | 4.984M |
| October 07, 2024 | 4.814M |
| October 04, 2024 | 4.698M |
| October 03, 2024 | 4.653M |
| October 02, 2024 | 4.429M |
| October 01, 2024 | 4.358M |
| September 30, 2024 | 4.259M |
| September 27, 2024 | 3.941M |
| September 26, 2024 | 4.162M |
| September 25, 2024 | 3.933M |
| September 24, 2024 | 4.096M |
| September 23, 2024 | 4.310M |
| September 20, 2024 | 3.695M |
| September 19, 2024 | 3.638M |
| September 18, 2024 | 3.474M |
| September 17, 2024 | 3.572M |
| September 16, 2024 | 3.458M |
| September 13, 2024 | 3.531M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.106M
Minimum
Jan 29 2024
148.24M
Maximum
Aug 14 2020
29.96M
Average
12.96M
Median
Market Cap Benchmarks
| Repligen Corp | 7.942B |
| Eli Lilly and Co | 711.91B |
| MEI Pharma Inc | 18.72M |
| Revance Therapeutics Inc | 402.83M |
| NovaBay Pharmaceuticals Inc | 3.517M |
Market Cap Related Metrics
| PS Ratio | 0.496 |
| Price to Book Value | 1.524 |
| Price | 4.50 |
| Earnings Yield | -245.1% |